Michigan Supplemental Rebate Program Takes “Best In Class” Approach
The Michigan Medicaid supplemental rebate program requires manufacturers to match the price of "best-in-class" agents or be subject to prior authorization
More from Archive
More from Pink Sheet
• By
The report gave examples of missed opportunities for innovation and patient access, as well as regulatory and operational problems that undermine the conduct of timely clinical trials in Europe.
• By
The Pink Sheet highlights recent comments and insights from pharma officials and executives on key issues we are covering.
• By
Japan looks set to press ahead with a reimbursement price cut for Eisai's Alzheimer's drug Leqembi following a cost-effectiveness review, despite differences with the company over methodology.